Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma

David T Vistica1, Paula M Krosky, Susan Kenney

  • 1Screening Technologies Branch, Developmental Therapeutics, National Cancer Institute, Frederick, MD 21702, USA. vistica@dtpax2.ncifcrf.gov

Related Concept Videos